More than one year since credit card giants Visa and MasterCard, along with major banks, offered a $7.25 billion settlement to end a class action over its swipe-fees, a New York district judge is set to hold a fairness hearing today. The hearing has been widely anticipated as some of the nation’s top retailers, including Wal-Mart and Target, have opted out of the record-setting offer.
The number of retailers that opted out of the offer has surpassed the 25 percent threshold, triggering Visa and MasterCard to revoke the settlement, which they declined to do last month.
Now, US District Judge John Gleeson will preside over the class action’s fairness hearing, though reports say a final decision on the settlement may not be made for several weeks.
More than seven million businesses throughout the US are part of the class; experts say the case could be the largest private antitrust cash settlement in history, though due to the high volume of opt-outs, the value of the offer has decreased to approximately $5.74 billion.
Retailers claim the practice of interchange fees, which charge retailers every time a card is swiped at the register and which has made more than $40 billion every year for the banks that issue the cards, violate antitrust law. The case was launched in 2005.
Full Content: CSNews
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas